يعرض 1 - 10 نتائج من 5,414 نتيجة بحث عن '"etanercept"', وقت الاستعلام: 1.13s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.

    المؤلفون: Tsukasa Matsubara1 mats@mayflower-hp.jp, Kou Katayama2, Akira Sagawa3, Masaaki Yoshida4, Takeshi Mitsuka5, Keisuke Hashimoto6, Tomomaro Izumihara7, Masakazu Kondo8, Tomomasa Izumiyama9, Nobumasa Miyake10, Ichiro Yoshii11, Motohiro Oribe12, Shigeki Momohara13, Keiko Funahashi1

    المصدر: Modern Rheumatology. Mar2024, Vol. 34 Issue 2, p307-312. 6p.

    مصطلحات موضوعية: *NOCEBOS, *ETANERCEPT, *SCIENTIFIC observation, *DRUG prices, *DISEASE duration, *RHEUMATOID arthritis

    مصطلحات جغرافية: JAPAN


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis.

    المؤلفون: Chen, Fangfang1 (AUTHOR), Lang, Yitian2 (AUTHOR), Geng, Shikai1 (AUTHOR), Wang, Xiaodong1 (AUTHOR), Lu, Liangjing1 (AUTHOR), Ye, Shuang1 (AUTHOR), Zhang, Le1,3 (AUTHOR) joyce66dbl@hotmail.com, Li, Ting1 (AUTHOR) leeting007@163.com

    المصدر: Clinical Rheumatology. Oct2023, Vol. 42 Issue 10, p2777-2786. 10p.

    مصطلحات موضوعية: *RHEUMATOID arthritis, *ETANERCEPT, *COST effectiveness, *METHOTREXATE


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings.

    المؤلفون: Deakin, Claire T., Littlejohn, Geoffrey O., Griffiths, Hedley, Ciciriello, Sabina, O'Sullivan, Catherine, Smith, Tegan, Youssef, Peter, Bird, Paul

    المصدر: Internal Medicine Journal; May2024, Vol. 54 Issue 5, p795-801, 7p

    مصطلحات موضوعية: COST control, RHEUMATOID arthritis, HEALTH policy, TREATMENT effectiveness, DESCRIPTIVE statistics, COST benefit analysis, TREATMENT duration, ETANERCEPT, BIOSIMILARS, SURVIVAL analysis (Biometry), CONFIDENCE intervals, DATA analysis software, COMPARATIVE studies, MEDICAL care costs

    مصطلحات جغرافية: AUSTRALIA


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy

    المؤلفون: Abdulaziz Boqaeid, Laila Layqah, Amgad Alonazy, Mutaz Althobaiti, Al-zahraa Almahlawi, Abdullah Al-Roqy, Omar Baharoon, Abdullah Alsaeedi, Jinan Shamou, Salim Baharoon

    المصدر: Journal of Infection and Public Health, Vol 17, Iss 6, Pp 1134-1141 (2024)

    مصطلحات موضوعية: Adalimumab, Etanercept, Tocilizumab, Rheumatoid arthritis, Tuberculosis infection, Infectious and parasitic diseases, RC109-216, Public aspects of medicine, RA1-1270

    وصف الملف: electronic resource

    العلاقة: http://www.sciencedirect.com/science/article/pii/S1876034124001291Test; https://doaj.org/toc/1876-0341Test

    الوصول الحر: https://doaj.org/article/ae8eff19078e4cd58d9b78a12ee1452bTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.

    المؤلفون: Feist, Eugen, Baraliakos, Xenofon, Behrens, Frank, Thaçi, Diamant, Plenske, Anja, Klaus, Pascal, Meng, Thomas

    المصدر: Rheumatology & Therapy; Apr2024, Vol. 11 Issue 2, p331-348, 18p

    مصطلحات موضوعية: PSORIATIC arthritis, SPONDYLOARTHROPATHIES, JOINT pain, PSORIASIS, ETANERCEPT, RHEUMATOID arthritis

    مصطلحات جغرافية: GERMANY

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.

    المؤلفون: Ling, Stephanie F, Yap, Chuan Fu, Nair, Nisha, Bluett, James, Morgan, Ann W, Isaacs, John D, Wilson, Anthony G, Hyrich, Kimme L, Barton, Anne, Plant, Darren

    المصدر: Rheumatology; Apr2024, Vol. 63 Issue 4, p1015-1021, 7p

    مصطلحات موضوعية: PROTEIN analysis, RESEARCH funding, RHEUMATOID arthritis, ANTIRHEUMATIC agents, TREATMENT effectiveness, ETANERCEPT, LONGITUDINAL method, PROTEOMICS, MASS spectrometry, BIOMARKERS, GENETICS


    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance.

    المؤلفون: Colina, Matteo, Khodeir, Micheline, Rimondini, Roberto, Valentini, Marco, Campomori, Federica, Corvaglia, Stefania, Campana, Gabriele

    المصدر: Clinical Drug Investigation; Mar2024, Vol. 44 Issue 3, p141-148, 8p

    مصطلحات موضوعية: RHEUMATOID arthritis, BIOSIMILARS, ETANERCEPT, ADALIMUMAB, PATIENT monitoring, FETAL monitoring


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events: A real-world finding.

    المؤلفون: Zhe Yu, Ling Gao, Yinshan Zang, Lu Cheng, Wenjia Gao, Yan Xu

    المصدر: Immunity, Inflammation & Disease; Feb2024, Vol. 12 Issue 2, p1-11, 11p

    مصطلحات موضوعية: PROPENSITY score matching, ADALIMUMAB, ETANERCEPT, RHEUMATOID arthritis

    مصطلحات جغرافية: CHINA

    النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.

    المؤلفون: Flouri, Irini, Goutakoli, Panagiota, Repa, Argyro, Bertsias, Antonios, Avgoustidis, Nestor, Eskitzis, Anastasios, Pitsigavdaki, Sofia, Kalogiannaki, Eleni, Terizaki, Maria, Bertsias, George, Sidiropoulos, Prodromos

    المصدر: Rheumatology International; Feb2024, Vol. 44 Issue 2, p249-261, 13p

    مصطلحات موضوعية: SPONDYLOARTHROPATHIES, TUMOR necrosis factors, ETANERCEPT, LONGITUDINAL method, COHORT analysis


    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management.

    المؤلفون: Singh, Sukhbir, Tiwary, Neha, Sharma, Neelam, Behl, Tapan, Antil, Anita, Anwer, Md. Khalid, Ramniwas, Seema, Sachdeva, Monika, Elossaily, Gehan M., Gulati, Monica, Ohja, Shreesh

    المصدر: Pharmaceuticals (14248247); Feb2024, Vol. 17 Issue 2, p248, 19p

    مصطلحات موضوعية: ANTIRHEUMATIC agents, CERTOLIZUMAB pegol, RHEUMATOID arthritis, RITUXIMAB, DRUGS, ABATACEPT, ETANERCEPT

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث